Two Sigma Advisers’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-24,900
Closed -$40.6K 2533
2023
Q4
$40.6K Buy
+24,900
New +$42.7K ﹤0.01% 2414
2020
Q4
Sell
-43,806
Closed -$187K 2483
2020
Q3
$187K Sell
43,806
-17,900
-29% -$82.4K ﹤0.01% 2171
2020
Q2
$283K Sell
61,706
-22,100
-26% -$143K ﹤0.01% 2141
2020
Q1
$320K Sell
83,806
-26,700
-24% -$98.9K ﹤0.01% 1986
2019
Q4
$438K Buy
110,506
+8,500
+8% +$24.8K ﹤0.01% 1924
2019
Q3
$252K Buy
+102,006
New +$297K ﹤0.01% 1979

Other funds holding IFRX

Two Sigma Advisers's IFRX Position: Q1 2024 in Review

Two Sigma Advisers sold out of InflaRx (IFRX) in Q1 2024, closing a stake of 24,900 shares — an estimated $40.6K sold.

Two Sigma Advisers first reported a position in IFRX in Q3 2019 and held it in 6 quarters. The position peaked at $438K in Q4 2019. 37 funds tracked by Wall St. Rank hold IFRX as of Q1 2024.

  • Two Sigma Advisers reported no remaining InflaRx position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 24,900 InflaRx shares in Q1 2024, an estimated $40.6K.
  • Two Sigma Advisers first reported a position in InflaRx in Q3 2019 and held it in 6 quarters.
  • Two Sigma Advisers's InflaRx position peaked at $438K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held InflaRx as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.